Phosphate binding by sucroferric oxyhydroxide ameliorates renal injury in the remnant kidney model

Yoshikazu Nemoto, Takanori Kumagai, Kenichi Ishizawa, Yutaka Miura, Takeshi Shiraishi, Chikayuki Morimoto, Kazuhiro Sakai, Hiroki Omizo, Osamu Yamazaki, Yoshifuru Tamura, Yoshihide Fujigaki, Hiroshi Kawachi, Makoto Kuro-o, Shunya Uchida, Shigeru Shibata

Research output: Contribution to journalArticle

Abstract

Recent clinical studies indicate that the disturbed phosphate metabolism in chronic kidney disease (CKD) may facilitate kidney injury; nonetheless, the causal role of phosphate in CKD progression remains to be elucidated. Here, we show that intestinal phosphate binding by sucroferric oxyhydroxide (SF) ameliorates renal injury in the rat remnant kidney model. Sprague-Dawley rats received 5/6 nephrectomy (RK) and had a normal chow or the same diet containing SF (RK + SF). RK rats showed increased plasma FGF23 and phosphate levels, which were suppressed by SF administration. Of note, albuminuria in RK rats was significantly ameliorated by SF at both 4 and 8 weeks. SF also attenuated glomerulosclerosis and tubulointerstitial injury. Moreover, several different approaches confirmed the protective effects on podocytes, explaining the attenuation of glomerulosclerosis and albuminuria observed in this study. As a possible mechanism, we found that SF attenuated renal inflammation and fibrosis in RK rats. Interestingly, von Kossa staining of the kidney revealed calcium phosphate deposition in neither RK nor RK + SF rats; however, plasma levels of calciprotein particles were significantly reduced by SF. These data indicate that latent positive phosphate balance accelerates CKD progression from early stages, even when overt ectopic calcification is absent.

Original languageEnglish (US)
Article number1732
JournalScientific Reports
Volume9
Issue number1
DOIs
StatePublished - Dec 1 2019
Externally publishedYes

Fingerprint

Phosphates
Kidney
Wounds and Injuries
Chronic Renal Insufficiency
Albuminuria
Disease Progression
sucroferric oxyhydroxide
Podocytes
Nephrectomy
Sprague Dawley Rats
Fibrosis
Staining and Labeling
Diet
Inflammation

ASJC Scopus subject areas

  • General

Cite this

Nemoto, Y., Kumagai, T., Ishizawa, K., Miura, Y., Shiraishi, T., Morimoto, C., ... Shibata, S. (2019). Phosphate binding by sucroferric oxyhydroxide ameliorates renal injury in the remnant kidney model. Scientific Reports, 9(1), [1732]. https://doi.org/10.1038/s41598-018-38389-3

Phosphate binding by sucroferric oxyhydroxide ameliorates renal injury in the remnant kidney model. / Nemoto, Yoshikazu; Kumagai, Takanori; Ishizawa, Kenichi; Miura, Yutaka; Shiraishi, Takeshi; Morimoto, Chikayuki; Sakai, Kazuhiro; Omizo, Hiroki; Yamazaki, Osamu; Tamura, Yoshifuru; Fujigaki, Yoshihide; Kawachi, Hiroshi; Kuro-o, Makoto; Uchida, Shunya; Shibata, Shigeru.

In: Scientific Reports, Vol. 9, No. 1, 1732, 01.12.2019.

Research output: Contribution to journalArticle

Nemoto, Y, Kumagai, T, Ishizawa, K, Miura, Y, Shiraishi, T, Morimoto, C, Sakai, K, Omizo, H, Yamazaki, O, Tamura, Y, Fujigaki, Y, Kawachi, H, Kuro-o, M, Uchida, S & Shibata, S 2019, 'Phosphate binding by sucroferric oxyhydroxide ameliorates renal injury in the remnant kidney model', Scientific Reports, vol. 9, no. 1, 1732. https://doi.org/10.1038/s41598-018-38389-3
Nemoto, Yoshikazu ; Kumagai, Takanori ; Ishizawa, Kenichi ; Miura, Yutaka ; Shiraishi, Takeshi ; Morimoto, Chikayuki ; Sakai, Kazuhiro ; Omizo, Hiroki ; Yamazaki, Osamu ; Tamura, Yoshifuru ; Fujigaki, Yoshihide ; Kawachi, Hiroshi ; Kuro-o, Makoto ; Uchida, Shunya ; Shibata, Shigeru. / Phosphate binding by sucroferric oxyhydroxide ameliorates renal injury in the remnant kidney model. In: Scientific Reports. 2019 ; Vol. 9, No. 1.
@article{eff63868adf24c3ba2bcca43d6ab77a2,
title = "Phosphate binding by sucroferric oxyhydroxide ameliorates renal injury in the remnant kidney model",
abstract = "Recent clinical studies indicate that the disturbed phosphate metabolism in chronic kidney disease (CKD) may facilitate kidney injury; nonetheless, the causal role of phosphate in CKD progression remains to be elucidated. Here, we show that intestinal phosphate binding by sucroferric oxyhydroxide (SF) ameliorates renal injury in the rat remnant kidney model. Sprague-Dawley rats received 5/6 nephrectomy (RK) and had a normal chow or the same diet containing SF (RK + SF). RK rats showed increased plasma FGF23 and phosphate levels, which were suppressed by SF administration. Of note, albuminuria in RK rats was significantly ameliorated by SF at both 4 and 8 weeks. SF also attenuated glomerulosclerosis and tubulointerstitial injury. Moreover, several different approaches confirmed the protective effects on podocytes, explaining the attenuation of glomerulosclerosis and albuminuria observed in this study. As a possible mechanism, we found that SF attenuated renal inflammation and fibrosis in RK rats. Interestingly, von Kossa staining of the kidney revealed calcium phosphate deposition in neither RK nor RK + SF rats; however, plasma levels of calciprotein particles were significantly reduced by SF. These data indicate that latent positive phosphate balance accelerates CKD progression from early stages, even when overt ectopic calcification is absent.",
author = "Yoshikazu Nemoto and Takanori Kumagai and Kenichi Ishizawa and Yutaka Miura and Takeshi Shiraishi and Chikayuki Morimoto and Kazuhiro Sakai and Hiroki Omizo and Osamu Yamazaki and Yoshifuru Tamura and Yoshihide Fujigaki and Hiroshi Kawachi and Makoto Kuro-o and Shunya Uchida and Shigeru Shibata",
year = "2019",
month = "12",
day = "1",
doi = "10.1038/s41598-018-38389-3",
language = "English (US)",
volume = "9",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Phosphate binding by sucroferric oxyhydroxide ameliorates renal injury in the remnant kidney model

AU - Nemoto, Yoshikazu

AU - Kumagai, Takanori

AU - Ishizawa, Kenichi

AU - Miura, Yutaka

AU - Shiraishi, Takeshi

AU - Morimoto, Chikayuki

AU - Sakai, Kazuhiro

AU - Omizo, Hiroki

AU - Yamazaki, Osamu

AU - Tamura, Yoshifuru

AU - Fujigaki, Yoshihide

AU - Kawachi, Hiroshi

AU - Kuro-o, Makoto

AU - Uchida, Shunya

AU - Shibata, Shigeru

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Recent clinical studies indicate that the disturbed phosphate metabolism in chronic kidney disease (CKD) may facilitate kidney injury; nonetheless, the causal role of phosphate in CKD progression remains to be elucidated. Here, we show that intestinal phosphate binding by sucroferric oxyhydroxide (SF) ameliorates renal injury in the rat remnant kidney model. Sprague-Dawley rats received 5/6 nephrectomy (RK) and had a normal chow or the same diet containing SF (RK + SF). RK rats showed increased plasma FGF23 and phosphate levels, which were suppressed by SF administration. Of note, albuminuria in RK rats was significantly ameliorated by SF at both 4 and 8 weeks. SF also attenuated glomerulosclerosis and tubulointerstitial injury. Moreover, several different approaches confirmed the protective effects on podocytes, explaining the attenuation of glomerulosclerosis and albuminuria observed in this study. As a possible mechanism, we found that SF attenuated renal inflammation and fibrosis in RK rats. Interestingly, von Kossa staining of the kidney revealed calcium phosphate deposition in neither RK nor RK + SF rats; however, plasma levels of calciprotein particles were significantly reduced by SF. These data indicate that latent positive phosphate balance accelerates CKD progression from early stages, even when overt ectopic calcification is absent.

AB - Recent clinical studies indicate that the disturbed phosphate metabolism in chronic kidney disease (CKD) may facilitate kidney injury; nonetheless, the causal role of phosphate in CKD progression remains to be elucidated. Here, we show that intestinal phosphate binding by sucroferric oxyhydroxide (SF) ameliorates renal injury in the rat remnant kidney model. Sprague-Dawley rats received 5/6 nephrectomy (RK) and had a normal chow or the same diet containing SF (RK + SF). RK rats showed increased plasma FGF23 and phosphate levels, which were suppressed by SF administration. Of note, albuminuria in RK rats was significantly ameliorated by SF at both 4 and 8 weeks. SF also attenuated glomerulosclerosis and tubulointerstitial injury. Moreover, several different approaches confirmed the protective effects on podocytes, explaining the attenuation of glomerulosclerosis and albuminuria observed in this study. As a possible mechanism, we found that SF attenuated renal inflammation and fibrosis in RK rats. Interestingly, von Kossa staining of the kidney revealed calcium phosphate deposition in neither RK nor RK + SF rats; however, plasma levels of calciprotein particles were significantly reduced by SF. These data indicate that latent positive phosphate balance accelerates CKD progression from early stages, even when overt ectopic calcification is absent.

UR - http://www.scopus.com/inward/record.url?scp=85061288646&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061288646&partnerID=8YFLogxK

U2 - 10.1038/s41598-018-38389-3

DO - 10.1038/s41598-018-38389-3

M3 - Article

VL - 9

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 1732

ER -